Related Experiment Video
Updated: Jun 9, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Isolated pharmacomechanical thrombectomy for the management of chronic DVT
Reji Pappy1, Elias B Hanna, Mazen S Abu-Fadel
1University of Oklahoma Health Sciences Center, Department of Medicine, Section of Cardiovascular Medicine, Oklahoma City, Oklahoma, USA. reji-pappy@ouhsc.edu
Insights
Interventional cardiologists can successfully manage chronic deep vein thrombosis (DVT) using pharmacomechanical thrombectomy. This approach helps prevent postthrombotic syndrome, a common complication of DVT.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Radiology
Background:
- Deep vein thrombosis (DVT) management traditionally falls outside interventional cardiology's scope.
- Preventing postthrombotic syndrome (PTS) is a key goal in DVT treatment.
- Chronic DVT presents unique management challenges.
Observation:
- A case series focused on managing chronic DVT.
- The study utilized pharmacomechanical thrombectomy.
- The Trellis device was employed for the procedure.
Findings:
- Successful thrombo-reduction was achieved in chronic DVT cases.
- Pharmacomechanical thrombectomy with the Trellis device proved effective.
- The intervention was performed by interventional cardiologists.
Implications:
- Interventional cardiology can play a role in chronic DVT management.
- This approach offers a potential strategy for PTS prevention.
- Further research may expand the role of interventional techniques in venous thromboembolism.
Abstract:
Thrombo-reduction in the setting of deep vein thrombosis (DVT) to prevent the postthrombotic syndrome has not been traditionally managed by interventional cardiologists. We report a case series of successful chronic DVT management with pharmacomechanical thrombectomy utilizing the Trellis device.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
